Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.

Research square·2026
Same author

Germline CDK12 variants in aggressive prostate cancer.

Cancer discovery·2026
Same author

Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.

Journal for immunotherapy of cancer·2026
Same author

Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

Nature·2026
Same author

Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.

Cancer·2026
Same author

3D genome architecture and epigenetic regulation of lineage identity in advanced prostate cancer.

Endocrinology·2026

相关实验视频

Updated: May 16, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.7K

高纯度CTCRNA测序识别前列腺癌血统表型 预测临床结果

Marina N Sharifi1,2, Jamie M Sperger1,2, Amy K Taylor1,2

  • 1Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin.

Cancer discovery
|April 1, 2025
PubMed
概括

治疗耐药性驱动致命的前列腺癌. 研究人员使用一种新的隔离技术确定了与转移性前列腺癌患者结果相关的四种不同的癌细胞系.

更多相关视频

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

13.4K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K

相关实验视频

Last Updated: May 16, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.7K
Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

13.4K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K

科学领域:

  • 在瘤学瘤学.
  • 遗传学 是一个遗传学.
  • 分子生物学分子生物学

背景情况:

  • 治疗耐药性是转移性前列腺癌死亡的主要原因.
  • 基因组变化和细胞系可塑性有助于治疗耐药性.

研究的目的:

  • 研究循环瘤细胞 (CTC) 现型在转移性前列腺癌预后中的作用.
  • 确定与治疗耐药性和患者结果相关的独特CTC血统.

主要方法:

  • 开发并使用一种新的高纯度方法来隔离循环瘤细胞 (CTC).
  • 进行了分离的CTC的转录分析,以表征血统表型.
  • 与转移性前列腺癌患者预后相关的已识别的CTC谱系表型.

主要成果:

  • 在转移性前列腺癌患者中确定了四种不同的CTC血统表型.
  • 在这四种血统表型中证明了差异性预后关联.
  • 在前列腺癌中建立了CTC谱系可塑性和治疗耐药性之间的联系.

结论:

  • 循环瘤细胞 (CTC) 血统表型是转移性前列腺癌的显著预后指标.
  • 新的CTC隔离和分析方法为治疗耐药性的机制提供了洞察力.
  • 了解这些血统表型可能会导致改善前列腺癌的治疗策略.